High molecular weight cytokeratin antibody (clone 34βE12): a sensitive marker for differentiation of high‐grade invasive urothelial carcinoma from prostate cancer
Authors:
- 31 January 2003
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 42 (2) , 167-172
Abstract
Aims: There is no well‐established positive immunomarker for urothelial carcinoma. We evaluated the diagnostic utility of high molecular weight cytokeratin (HMWCK) antibody clone 34βE12 in differentiating high‐grade invasive urothelial carcinoma from prostate cancer.Methods and results: Formalin‐fixed paraffin‐embedded sections from 28 cases of high‐grade invasive urothelial carcinoma (20 not otherwise specified (UC‐NOS), eight with glandular differentiation) and 20 cases of poorly differentiated prostate carcinoma were immunostained with a monoclonal antibody to carcinoembryonic antigen (CEA), clone 85A12 and with HMWCK antibody clone 34βE12 after microwave pretreatment or protease 24 predigestion. All cases of UC‐NOS expressed HMWCK on 34βE12 immunostaining after microwaving or enzyme predigestion. Immunoreactivity was intense and diffuse in all the cases after microwave pretreatment, whilst with enzyme predigestion immunoreactivity was sometimes patchy with Conclusions: HMWCK antibody clone 34βE12, particularly when used with microwave heat retrieval, is a very sensitive positive marker for high‐grade invasive urothelial carcinoma.Keywords
This publication has 11 references indexed in Scilit:
- Polyclonal Anti-PSA Is More Sensitive but Less Specific Than Monoclonal Anti-PSAAmerican Journal of Clinical Pathology, 2002
- A Clinicopathologic Analysis of Urothelial Carcinomas Diagnosed on Prostate Needle BiopsyAmerican Journal of Surgical Pathology, 2001
- Immunophenotype of High-Grade Prostatic Adenocarcinoma and Urothelial CarcinomaLaboratory Investigation, 2000
- Uroplakin III Is a Highly Specific and Moderately Sensitive Immunohistochemical Marker for Primary and Metastatic Urothelial CarcinomasAmerican Journal of Clinical Pathology, 2000
- Rare Expression of High-Molecular-Weight Cytokeratin in Adenocarcinoma of the Prostate GlandAmerican Journal of Surgical Pathology, 1999
- Thrombomodulin Expression in Transitional Cell CarcinomaAmerican Journal of Clinical Pathology, 1998
- The Utility of Basal Cell—Specific Anti-Cytokeratin Antibody (34βE12) in the Diagnosis of Prostate CancerAmerican Journal of Surgical Pathology, 1995
- PSA AND PAP AS IMMUNOHISTOCHEMICAL MARKERS IN PROSTATE CANCERUrologic Clinics of North America, 1993
- Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate CarcinomaAmerican Journal of Surgical Pathology, 1989
- Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the ProstateAmerican Journal of Clinical Pathology, 1984